XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -44.39%104M | 8.06%67M | -17.24%120M | -58.06%39M | -7.96%-122M | 303.26%187M | 395.24%62M | 8.21%145M | 232.14%93M | 51.50%-113M |
Net income from continuing operations | -29.59%-127M | 41.67%-63M | -94.57%7M | 57.89%30M | 26.81%-101M | 65.37%-98M | 76.11%-108M | 130.36%129M | -78.89%19M | -700.00%-138M |
Operating gains losses | 93.75%-11M | 300.00%4M | 92.35%-13M | 40.00%-3M | 0.00%1M | -245.10%-176M | -112.50%-2M | -5,566.67%-170M | 44.44%-5M | 101.82%1M |
Depreciation and amortization | 1.02%198M | 0.00%47M | -4.00%48M | -2.04%48M | 10.00%55M | -8.41%196M | -14.55%47M | -5.66%50M | -10.91%49M | -1.96%50M |
Deferred tax | 93.94%-2M | 600.00%15M | -77.78%2M | 12.50%9M | 40.43%-28M | 65.63%-33M | 97.06%-3M | -10.00%9M | 300.00%8M | -683.33%-47M |
Other non cash items | 0.00%-14M | 50.00%-2M | -66.67%-5M | 20.00%-4M | -50.00%-3M | 44.00%-14M | 42.86%-4M | 0.00%-3M | 37.50%-5M | 71.43%-2M |
Change In working capital | -91.19%20M | -32.88%49M | -38.52%75M | -366.67%-48M | -500.00%-56M | 163.23%227M | 621.43%73M | 1,009.09%122M | 116.36%18M | 105.69%14M |
-Change in receivables | -104.73%-8M | -26.53%72M | -79.66%12M | -457.14%-78M | -153.85%-14M | 211.92%169M | 1,860.00%98M | 1,083.33%59M | 87.61%-14M | 170.27%26M |
-Change in payables and accrued expense | -38.30%-65M | 20.34%-47M | 21.43%34M | 60.00%8M | -185.71%-60M | 75.90%-47M | -5.36%-59M | -9.68%28M | 150.00%5M | 87.79%-21M |
-Change in other current assets | -11.43%93M | -29.41%24M | -17.14%29M | -18.52%22M | 100.00%18M | 907.69%105M | -8.11%34M | 350.00%35M | 2,600.00%27M | 124.32%9M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -44.39%104M | 8.06%67M | -17.24%120M | -58.06%39M | -7.96%-122M | 303.26%187M | 395.24%62M | 8.21%145M | 232.14%93M | 51.50%-113M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -30.51%-77M | -15.00%-23M | 0.00%-19M | -26.67%-19M | -220.00%-16M | -7.27%-59M | 33.33%-20M | 40.63%-19M | 48.28%-15M | -113.89%-5M |
Net PPE purchase and sale | -8.33%-78M | -20.00%-24M | 0.00%-18M | -12.50%-18M | 0.00%-18M | 33.94%-72M | 23.08%-20M | 33.33%-18M | 40.74%-16M | 37.93%-18M |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | -67.57%12M | --0 | 80.00%-1M | 150.00%1M | -75.00%12M |
Net other investing changes | 0.00%1M | ---- | ---- | ---1M | 100.00%2M | -94.12%1M | --0 | --0 | --0 | -94.12%1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -30.51%-77M | -15.00%-23M | 0.00%-19M | -26.67%-19M | -220.00%-16M | -7.27%-59M | 33.33%-20M | 40.63%-19M | 48.28%-15M | -113.89%-5M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 90.75%-21M | 70.37%-24M | 14.19%-133M | 111.76%2M | 415.38%134M | 39.63%-227M | -800.00%-81M | -82.35%-155M | 62.22%-17M | 110.97%26M |
Net issuance payments of debt | 102.82%5M | 76.00%-18M | 3.01%-129M | 228.57%9M | 276.32%143M | -45.08%-177M | -7,600.00%-75M | -682.35%-133M | -187.50%-7M | 133.33%38M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | 48.00%-26M | 0.00%-6M | 81.82%-4M | 30.00%-7M | 25.00%-9M | 68.15%-50M | 40.00%-6M | -37.50%-22M | -25.00%-10M | 90.24%-12M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 90.75%-21M | 70.37%-24M | 14.19%-133M | 111.76%2M | 415.38%134M | 39.63%-227M | -800.00%-81M | -82.35%-155M | 62.22%-17M | 110.97%26M |
Net cash flow | ||||||||||
Beginning cash position | -45.41%119M | -32.91%106M | -27.13%137M | ---- | -45.41%119M | -70.66%218M | -42.96%158M | -28.24%188M | ---- | -70.66%218M |
Current changes in cash | 106.06%6M | 151.28%20M | -10.34%-32M | ---- | ---- | 81.07%-99M | 35.00%-39M | -270.59%-29M | ---- | ---- |
Effect of exchange rate changes | ---1M | ---2M | 200.00%1M | --0 | --0 | --0 | --0 | 50.00%-1M | 200.00%1M | --0 |
End cash Position | 4.20%124M | 4.20%124M | -32.91%106M | ---- | ---- | -45.41%119M | -45.41%119M | -42.96%158M | ---- | ---- |
Free cash flow | -77.39%26M | 2.38%43M | -19.69%102M | -72.73%21M | -6.87%-140M | 157.21%115M | 189.36%42M | 18.69%127M | 7,600.00%77M | 50.00%-131M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |